| Cutting edge: human CD4+ CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells N Misra, J Bayry, S Lacroix-Desmazes, MD Kazatchkine, SV Kaveri The Journal of Immunology 172 (8), 4676-4680, 2004 | 619 | 2004 |
| Surface hydrophobin prevents immune recognition of airborne fungal spores V Aimanianda, J Bayry, S Bozza, O Kniemeyer, K Perruccio, SR Elluru, ... Nature 460 (7259), 1117-1121, 2009 | 595 | 2009 |
| Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies MS Maddur, P Miossec, SV Kaveri, J Bayry The American journal of pathology 181 (1), 8-18, 2012 | 498 | 2012 |
| Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin J Bayry, S Lacroix-Desmazes, C Carbonneil, N Misra, V Donkova, ... Blood 101 (2), 758-765, 2003 | 331 | 2003 |
| Expansion of CD4+ CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis A Ephrem, S Chamat, C Miquel, S Fisson, L Mouthon, G Caligiuri, ... Blood 111 (2), 715-722, 2008 | 282 | 2008 |
| Intravenous immunoglobulin: an update on the clinical use and mechanisms of action VS Negi, S Elluru, S Siberil, S Graff-Dubois, LUC Mouthon, ... Journal of clinical immunology 27 (3), 233-245, 2007 | 267 | 2007 |
| VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors S Dasgupta, Y Repessé, J Bayry, AM Navarrete, B Wootla, S Delignat, ... Blood 109 (2), 610-612, 2006 | 189 | 2006 |
| Hydrophobins—unique fungal proteins J Bayry, V Aimanianda, JI Guijarro, M Sunde, JP Latge PLoS pathogens 8 (5), e1002700, 2012 | 188 | 2012 |
| Modulation of the cellular immune system by intravenous immunoglobulin T Tha-In, J Bayry, HJ Metselaar, SV Kaveri, J Kwekkeboom Trends in immunology 29 (12), 608-615, 2008 | 185 | 2008 |
| Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. J Bayry, N Misra, V Latry, F Prost, S Delignat, S Lacroix-Desmazes, ... Transfus Clin Biol 10 (3), 165-169, 2003 | 177 | 2003 |
| Common variable immunodeficiency is associated with defective functions of dendritic cells J Bayry, S Lacroix-Desmazes, MD Kazatchkine, L Galicier, Y Lepelletier, ... Blood 104 (8), 2441-2443, 2004 | 162 | 2004 |
| A CCR4 antagonist combined with vaccines induce antigen-specific CD8+ T cells and tumor immunity against self antigens H Pere, Y Montier, J Bayry, F Quintin-Colonna, N Merillon, E Dransart, ... Blood 118 (18), 4853-4862, 2011 | 157 | 2011 |
| Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications S André, DF Tough, S Lacroix-Desmazes, SV Kaveri, J Bayry The American journal of pathology 174 (5), 1575-1587, 2009 | 143 | 2009 |
| High levels of catalytic antibodies correlate with favorable outcome in sepsis S Lacroix-Desmazes, J Bayry, SV Kaveri, D Hayon-Sonsino, N Thorenoor, ... Proceedings of the National Academy of Sciences 102 (11), 4109-4113, 2005 | 140 | 2005 |
| T Cell–derived IL-22 amplifies IL-1β–driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes E Dalmas, N Venteclef, C Caer, C Poitou, I Cremer, J Aron-Wisnewsky, ... Diabetes 63 (6), 1966-1977, 2014 | 135 | 2014 |
| Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin MS Maddur, J Vani, P Hegde, S Lacroix-Desmazes, SV Kaveri, J Bayry Journal of Allergy and Clinical Immunology 127 (3), 823-830. e7, 2011 | 131 | 2011 |
| Low‐dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer I Shevchenko, S Karakhanova, S Soltek, J Link, J Bayry, J Werner, ... International journal of cancer 133 (1), 98-107, 2013 | 130 | 2013 |
| Intravenous immunoglobulin therapy in rheumatic diseases J Bayry, VS Negi, SV Kaveri Nature Reviews Rheumatology 7 (6), 349, 2011 | 126 | 2011 |
| In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination J Bayry, EZ Tchilian, MN Davies, EK Forbes, SJ Draper, SV Kaveri, ... Proceedings of the National Academy of Sciences 105 (29), 10221-10226, 2008 | 125 | 2008 |
| Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy SV Kaveri, MS Maddur, P Hegde, S Lacroix‐Desmazes, J Bayry Clinical & Experimental Immunology 164, 2-5, 2011 | 120 | 2011 |
